Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease

Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease

Item
http://www.wikidata.org/entity/Q28273500
Pharmacotherapies for obesity: past, current, and future therapiesTesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese ratAnti-Obesity Drugs: A Review about Their Effects and SafetyTesofensine – a novel potent weight loss medicineSubjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersPolymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetesObesity: Current and potential pharmacotherapeutics and targets.Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine.Present and future: pharmacologic treatment of obesityMonoamine reuptake inhibitors in Parkinson's disease.Neuropsychiatric adverse effects of centrally acting antiobesity drugs.Anti-obesity drugs: a review about their effects and their safety.[Recent progress and novel perspectives on obesity pharmacotherapy].The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men.Centrally Acting Agents for Obesity: Past, Present, and Future
P2860

Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease

Item
http://www.wikidata.org/entity/Q28273500
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@ast
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@en
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@nl
type
label
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@ast
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@en
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@nl
prefLabel
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@ast
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@en
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921